Crops News

ChemChina turns to U.S. antitrust for Syngenta deal


The ChemChina-Syngenta acquisition is making some noise again in mainstream media. The Chinese state-owned chemical company is seeking approval from the U.S. anti-trust regulator’s approval for the proposed $43 billion acquisition  of Syngenta.

ChemChina filed documentation required by the Hart-Scott-Rodino Act under the Federal Trade Commission (FTC). The FTC, along with the Justice Department, has 30 days to either approve or ask for a second request.

According to reports, the deal is the largest foreign acquisition by a Chinese company and has already won approvals from regulators in several markets, including a U.S. national security panel and Australia’s competitive landscape.

On Feb. 3, 2016, Syngenta announced that ChemChina has offered to acquire 100 percent of the outstanding share capital of Syngenta at a price of USD 465 per ordinary share plus a special dividend of CHF 5 to be paid conditional upon, and prior to, closing.

Sponsored Content on AGDaily
Any views or opinions expressed in this article are those of the author and do not reflect those of AGDAILY. Comments on this article reflect the sole opinions of their writers.